Skip to main content

Acorda Therapeutics, Inc.

ACORDelisted Apr 25, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001008848

Acorda Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Jun 23, 2023; 17 institutions reported holding it in 13F filings for Q1 2024, worth $2.13M in total; no superinvestor held it.

13F holders, Q3 2024

Institutional positions in Acorda Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

ACOR is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024

Institutional holders
0
−2 vs. Q2 2024
Shares held
0
−33.7K (−100.0%) vs. Q2 2024
Total value
$0
−$8.00K (−100.0%) vs. Q2 2024
New holders
0
0 more added
Sold out
2
0 more reduced

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 0 institutions
Q1 2021: 37 institutionsQ2 2021: 37 institutionsQ3 2021: 36 institutionsQ4 2021: 34 institutionsQ1 2022: 34 institutionsQ2 2022: 35 institutionsQ3 2022: 36 institutionsQ4 2022: 36 institutionsQ1 2023: 30 institutionsQ2 2023: 15 institutionsQ3 2023: 16 institutionsQ4 2023: 15 institutionsQ1 2024: 17 institutionsQ2 2024: 2 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $0
Q1 2021: $18.0MQ2 2021: $18.1MQ3 2021: $14.7MQ4 2021: $9.48MQ1 2022: $5.42MQ2 2022: $3.08MQ3 2022: $1.91MQ4 2022: $4.09MQ1 2023: $3.71MQ2 2023: $1.94MQ3 2023: $2.30MQ4 2023: $2.33MQ1 2024: $2.13MQ2 2024: $8.00KQ3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding ACOR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20242$8.00K
Q1 202417$2.13M
Q4 202315$2.33M
Q3 202316$2.30M
Q2 202315$1.94M
Q1 202330$3.71M
Q4 202236$4.09M
Q3 202236$1.91M
Q2 202235$3.08M
Q1 202234$5.42M
Q4 202134$9.48M
Q3 202136$14.7M
Q2 202137$18.1M
Q1 202137$18.0M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Acorda Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding ACOR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Acadian Asset Management LLC0$00.00%−33,691−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−1−100.0%Sold out